- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platinum-Sensitive Primary Peritoneal Carcinoma
Total 6694 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Estrogen Receptor Positive | PostmenopausalUnited States
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
Gangnam Severance HospitalUnknownPeritoneal Carcinomatosis | Advanced Gastric CancerKorea, Republic of
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian NeoplasmUnited States
-
The Netherlands Cancer InstituteZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingMRI | Colorectal Cancer | Peritoneal CarcinomatosisNetherlands
-
University of California, IrvineRecruitingGastric Cancer | Peritoneal Carcinomatosis | Gastroesophageal Junction AdenocarcinomaUnited States
-
University of VirginiaNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Royal College of Obstetricians and GynecologistsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
Radboud University Medical CenterDutch Cancer SocietyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaNetherlands
-
Laval UniversityCiusss de L'Est de l'Île de MontréalRecruitingColorectal Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Appendix Cancer | Appendix NeoplasmCanada
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
Royal Marsden NHS Foundation TrustJanssen, LPRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)United Kingdom
-
Jena University HospitalBayerRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Germany
-
University of Michigan Rogel Cancer CenterRecruitingProstate Cancer | Oligometastatic Disease | Castrate Sensitive Prostate CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Astellas Pharma China, Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerChina
-
Ångstrom PharmaceuticalsCompletedOvarian Cancer | Primary Peritoneal CarcinomaUnited States
-
Masonic Cancer Center, University of MinnesotaIncyte CorporationCompletedOvarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Merck Sharp & Dohme LLCRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly
-
Boston Scientific CorporationCompletedOvarian Diseases | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Carcinoma | Fallopian Tube Adenocarcinoma | High Grade Serous Carcinoma | Ovary Cancer | Adnexal MassUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
ImunonBreak Through Cancer FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Hoffmann-La RocheCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, United States
-
Roswell Park Cancer InstituteAstraZenecaActive, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Serous AdenocarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)WithdrawnRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
Merck Sharp & Dohme LLCTerminatedOvarian Cancer | Primary Peritoneal Cavity Cancer
-
University of ArkansasRecruitingCastration Sensitive Prostate CancerUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingChemotherapy Effect | DNA Damage Repair Deficiency | Chemotherapeutic Toxicity | Hormone Sensitive Metastatic Prostate CancerChina
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHormone Sensitive Prostate CancerChina
-
Vilnius UniversityNational Cancer Institute (NCI); Vilnius University Hospital Santaros KlinikosRecruitingGastric Cancer | Peritoneal CarcinomatosisLithuania
-
Ruijin HospitalNot yet recruitingFallopian Tube Cancer | Peritoneal Cancer | Primary Ovarian Cancer
-
Institut du Cancer de Montpellier - Val d'AurelleRecruitingPeritoneal Carcinomatosis | Peritoneal MesotheliomaFrance
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingPeritoneal Carcinomatosis | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction AdenocarcinomaChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedBreast Carcinoma | Fallopian Tube Carcinoma | Ovarian Neoplasm | Primary Peritoneal CarcinomaUnited States
-
Instituto do Cancer do Estado de São PauloRecruitingGastric Cancer | Peritoneal CarcinomatosisBrazil
-
British Columbia Cancer AgencyOzmosis Research Inc.UnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaCanada
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
Xiao X. Wei, MDBristol-Myers SquibbActive, not recruitingProstate Adenocarcinoma | Hormone Sensitive Prostate Cancer | Metastasis Prostate AdenocarcinomaUnited States
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
MaxCyte, Inc.CTI Clinical Trial and Consulting ServicesTerminatedFallopian Tube Adenocarcinoma | Peritoneal Mesothelioma | Primary Peritoneal Carcinoma | Adenocarcinoma of the OvaryUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian CarcinomaUnited States
-
Dana-Farber Cancer InstituteCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
University of PittsburghGenentech, Inc.; Novartis PharmaceuticalsCompletedStudy of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer (RADBEV)Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States